{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:26:58Z","timestamp":1794378418948,"version":"4.9.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>Mismatch repair deficiency (MMRd) is identified in a small subset of prostate cancers and has implications for therapy selection and germline testing. The clinicopathologic spectrum of primary MMRd prostate cancer remains incompletely characterized. We evaluated 32 primary treatment-naive MMRd prostatic adenocarcinomas identified at a single institution. Grade group distribution included GG5 (n=12, 38%), GG4 (n=4, 13%), GG3 (n=7, 22%), and GG2 (n=9, 28%). Intraductal and\/or invasive cribriform carcinoma was identified in 78% of cases overall and in 78% of GG2 tumors. MMR protein loss predominantly involved MSH2\/MSH6 (78%), with isolated MSH6 loss in 16% and MLH1\/PMS2 loss in 6%. Concordant pathogenic MMR gene alterations were identified on targeted NGS in all cases, while concurrent Tier 1\/2 HRR gene alterations were present in 11 cases (35%), including ATM, BRCA1, and BRCA2. Germline testing performed in 15 cases identified Lynch syndrome in 5 (33%). MMR immunohistochemistry performed on multiple tissue blocks in 14 cases revealed discordant MMR status between tumor foci in 8 cases (57%), with MMR deficiency consistently restricted to the highest-grade focus and retained expression in spatially separate lower-grade foci. One additional case demonstrated apparent intratumoral heterogeneity within a single biopsy core, with MMR deficiency restricted to a higher-grade component and retained expression in the adjacent lower-grade tumor. These findings demonstrate a broader clinicopathologic spectrum of primary MMRd prostate cancer than previously recognized. Frequent discordance of MMR status between tumor foci highlights the importance of evaluating the highest-grade tumor focus when assessing multifocal primary prostate cancer.<\/jats:p>","DOI":"10.1097\/pas.0000000000002623","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:00:23Z","timestamp":1789459223000},"page":"1407-1412","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic Spectrum and Intraprostatic Heterogeneity of Primary Mismatch Repair-Deficient Prostate Cancer"],"prefix":"10.1097","volume":"50","author":[{"given":"Darrell","family":"Martin","sequence":"first","affiliation":[{"name":"Division of Anatomic Pathology"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol C.","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9onie","family":"Beauchamp","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mansoor","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia M.","family":"Green","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamini","family":"Selvarajah","sequence":"additional","affiliation":[{"name":"Division of Genome Diagnostics, Laboratory Medicine Program, University Health Network"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Prendeville","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology"},{"name":"Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"R1-20261111","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1158\/1078-0432.CCR-17-0955","article-title":"MSH2 loss in primary prostate cancer","volume":"23","author":"Guedes","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R2-20261111","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol"},{"key":"R3-20261111","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/his.14645","article-title":"Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer","volume":"80","author":"Wyvekens","year":"2022","journal-title":"Histopathology"},{"key":"R4-20261111","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1158\/1078-0432.CCR-24-1210","article-title":"Prevalence of mismatch repair deficiency in primary prostate cancer in a large prospective cohort","volume":"31","author":"McNevin","year":"2025","journal-title":"Clin Cancer Res"},{"key":"R5-20261111","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1158\/0008-5472.CAN-03-2879","article-title":"Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation","volume":"64","author":"Nakagawa","year":"2004","journal-title":"Cancer Res"},{"key":"R6-20261111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00283","article-title":"Prospective comprehensive genomic profiling of primary and metastatic prostate tumors","volume":"3","author":"Chung","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"R7-20261111","doi-asserted-by":"crossref","first-page":"1277233","DOI":"10.3389\/fonc.2023.1277233","article-title":"Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"key":"R8-20261111","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.euo.2025.04.016","article-title":"Efficacy of Anti-PD-(L)1 immunotherapy in patients with DNA mismatch repair-deficient metastatic castration-resistant prostate cancer","volume":"8","author":"van Wilpe","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"R9-20261111","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ng.3315","article-title":"Spatial genomic heterogeneity within localized, multifocal prostate cancer","volume":"47","author":"Boutros","year":"2015","journal-title":"Nat Genet"},{"key":"R10-20261111","doi-asserted-by":"crossref","first-page":"100489","DOI":"10.1016\/j.modpat.2024.100489","article-title":"Somatic tumor testing in prostate cancer: experience of a tertiary care center including pathologist-driven reflex testing of localized tumors at diagnosis","volume":"37","author":"Prendeville","year":"2024","journal-title":"Mod Pathol"},{"key":"R11-20261111","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","article-title":"ISUP consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R12-20261111","first-page":"3990","article-title":"Diagnosis of \u201ccribriform\u201d prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations","volume":"11","author":"Shah","year":"2021","journal-title":"Am J Cancer Res"},{"key":"R13-20261111","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod Pathol"},{"key":"R14-20261111","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00428-024-03789-6","article-title":"Primary mismatch repair-deficient prostate cancer can be identified prospectively in prostate biopsies and radical prostatectomies","volume":"484","author":"Acosta","year":"2024","journal-title":"Virchows Arch"},{"key":"R15-20261111","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2018.10.009","article-title":"Clinical features and therapeutic outcomes in men with advanced prostate cancer and DNA mismatch repair gene mutations","volume":"75","author":"Antonarakis","year":"2019","journal-title":"Eur Urol"},{"key":"R16-20261111","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00428-019-02701-x","article-title":"High homogeneity of mismatch repair deficiency in advanced prostate cancer","volume":"476","author":"Fraune","year":"2020","journal-title":"Virchows Arch"},{"key":"R17-20261111","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1038\/ncomms5988","article-title":"Complex MSH2 and MSH6 mutations in hypermutated microsatellite-unstable advanced prostate cancer","volume":"5","author":"Pritchard","year":"2014","journal-title":"Nat Commun"},{"key":"R18-20261111","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/1078-0432.CCR-23-3403","article-title":"Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer","volume":"30","author":"Lenis","year":"2024","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"R19-20261111","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/pros.70091","article-title":"Spatial characteristics of intraductal carcinoma of the prostate","volume":"86","author":"Dupuis","year":"2026","journal-title":"Prostate"},{"key":"R20-20261111","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PAS.0000000000002158","article-title":"A comprehensive study of heterogeneous mismatch repair expression in solid tumors reveals different immunohistochemical patterns and distinct genetic mechanisms","volume":"48","author":"Wang","year":"2024","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:00:26Z","timestamp":1794376826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002623","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"2026-06-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}